These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20335186)

  • 1. Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC).
    Corona A; Bertolini G; Lipman J; Wilson AP; Singer M
    J Antimicrob Chemother; 2010 Jun; 65(6):1276-85. PubMed ID: 20335186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic strategies in the treatment of infection in critically ill patients].
    Schierbeck J; Kolmos HJ
    Ugeskr Laeger; 2007 Feb; 169(8):699-702. PubMed ID: 17313920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.
    Malacarne P; Rossi C; Bertolini G;
    J Antimicrob Chemother; 2004 Jul; 54(1):221-4. PubMed ID: 15190030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of treatment duration for bacteraemia in the critically ill: a multinational survey.
    Corona A; Bertolini G; Ricotta AM; Wilson A; Singer M
    J Antimicrob Chemother; 2003 Nov; 52(5):849-52. PubMed ID: 14519681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy.
    Corona A; Wilson AP; Grassi M; Singer M
    J Antimicrob Chemother; 2004 Oct; 54(4):809-17. PubMed ID: 15375106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course monotherapy strategy for treating bacteremia in the critically ill.
    Corona A; Wilson AP; Grassi M; Singer M
    Minerva Anestesiol; 2006 Oct; 72(10):841-57. PubMed ID: 17006421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
    Metan G; Sariguzel F; Sumerkan B
    Eur J Intern Med; 2009 Sep; 20(5):540-4. PubMed ID: 19712862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
    Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
    J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.
    Mettler J; Simcock M; Sendi P; Widmer AF; Bingisser R; Battegay M; Fluckiger U; Bassetti S
    BMC Infect Dis; 2007 Mar; 7():21. PubMed ID: 17386104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
    Donaldson AD; Razak L; Liang LJ; Fisher DA; Tambyah PA
    Int J Antimicrob Agents; 2009 Sep; 34(3):246-51. PubMed ID: 19628129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
    Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
    J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia.
    Al-Otaibi FE; Kambal AM; Baabbad RA
    Saudi Med J; 2004 Jan; 25(1):21-5. PubMed ID: 14758373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
    Golestaneh L; Laut J; Rosenberg S; Zhang M; Mokrzycki MH
    Nephrol Dial Transplant; 2006 May; 21(5):1328-33. PubMed ID: 16421157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
    Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.